Staar Surgical Co.

NASDAQ:STAA  
67.04
+4.18 (+6.65%)
Products

Staar Surgical Announces U.S. FDA Approval Of Evo Visian Implantable Collamer Lenses

Published: 03/28/2022 07:08 GMT
Staar Surgical Co. (STAA) - Staar Surgical Announces U.S. FDA Approval of Evo Visian® Implantable Collamer® Lenses.commercialization of Evo in U.S. Will Begin Immediately.